Opicinumab (BIIB033)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opicinumab (BIIB033), covering 2016-12-08 to 2016-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes [Phase 1]